Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

TMEM19 Inhibitors

TMEM19 inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the TMEM19 protein, a transmembrane protein encoded by the TMEM19 gene. Although the precise biological functions of TMEM19 are not fully elucidated, transmembrane proteins like TMEM19 are generally involved in various cellular processes such as signaling, transport, and maintaining cellular homeostasis. TMEM19 is thought to play a role in the organization of cellular membranes, possibly influencing the function of ion channels, receptors, or other membrane-associated proteins. Inhibitors of TMEM19 are developed to disrupt its normal activity, allowing researchers to study its role in cellular processes, particularly those related to membrane dynamics and signaling pathways.

The development of TMEM19 inhibitors involves a comprehensive approach that begins with a detailed analysis of the protein's structure and its functional domains. Structural biology techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are employed to determine the three-dimensional configuration of TMEM19. This structural information is essential for identifying key regions of the protein, such as the transmembrane domains and potential binding sites, where inhibitors could effectively target and modulate the protein's activity. Computational tools, including molecular docking and virtual screening, are then utilized to identify small molecules that can specifically bind to these sites with high affinity and selectivity. Once potential inhibitors are identified, they are synthesized and subjected to rigorous in vitro testing to evaluate their binding properties, specificity, and inhibitory potency. These compounds are further optimized through iterative cycles of chemical refinement to enhance their effectiveness and stability. The study of TMEM19 inhibitors not only provides insights into the specific functions of this transmembrane protein but also contributes to a broader understanding of the molecular mechanisms that regulate membrane dynamics, signaling, and cellular homeostasis within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Concanamycin A

80890-47-7sc-202111
sc-202111A
sc-202111B
sc-202111C
50 µg
200 µg
1 mg
5 mg
$65.00
$162.00
$650.00
$2550.00
109
(2)

Inhibits V-ATPase, which could disrupt intracellular pH and ion homeostasis, indirectly inhibiting TMEM19 activity that relies on pH-sensitive processes.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Inhibits V-ATPase, leading to altered endosomal/lysosomal acidification, potentially inhibiting TMEM19's role in trafficking or protein turnover.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), affecting calcium homeostasis and potentially disrupting TMEM19-related signaling.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Inhibits tyrosine kinases, which could interfere with phosphorylation-dependent processes that TMEM19 might be involved in.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$87.00
44
(2)

Inhibits dynamin-dependent endocytosis, potentially affecting TMEM19's role in membrane trafficking or signal transduction.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$145.00
$442.00
64
(4)

Disrupts actin polymerization, which could inhibit TMEM19's assumed role in maintaining cytoskeletal structure or related signaling pathways.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$27.00
$52.00
37
(1)

Inhibits IP3 receptors and store-operated Ca2+ entry, potentially inhibiting TMEM19's function if it is involved in calcium signaling.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$89.00
$262.00
13
(1)

Inhibits myosin light chain kinase, potentially affecting cellular contractility and motility processes that TMEM19 might be associated with.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

Inhibits protein kinase C, which could inhibit TMEM19's role in signal transduction pathways that involve protein kinase C activity.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$260.00
$799.00
36
(2)

Binds to actin monomers and prevents polymerization, which could inhibit TMEM19's role in cytoskeletal-dependent processes or vesicle trafficking.